Victoria M Raymond Selected Research

Paraganglioma (Paragangliomas)

8/2014

The clinical phenotype of SDHC-associated hereditary paraganglioma syndrome (PGL3).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Victoria M Raymond Research Topics

Disease

25	Neoplasms (Cancer) 05/2024 - 03/2011
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2017
6	Colorectal Neoplasms (Colorectal Cancer) 05/2024 - 01/2019
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 12/2019
2	Residual Neoplasm 05/2024 - 10/2021
2	Adenocarcinoma 01/2024 - 11/2017
2	Stomach Neoplasms (Stomach Cancer) 12/2019 - 01/2019
1	Cholangiocarcinoma 01/2022
1	Diarrhea 11/2021
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Appendiceal Neoplasms (Appendix Cancer) 01/2020
1	Microsatellite Instability 12/2019
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Urogenital Neoplasms 01/2019
1	Peritoneal Neoplasms 08/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2018
1	Paraganglioma (Paragangliomas) 08/2014
1	Kidney Neoplasms (Kidney Cancer) 03/2012
1	Hereditary leiomyomatosis and renal cell cancer 03/2012
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 03/2011

Drug/Important Bio-Agent (IBA)

21	Circulating Tumor DNAIBA 05/2024 - 01/2017
13	Cell-Free Nucleic AcidsIBA 05/2024 - 01/2018
4	DNA (Deoxyribonucleic Acid)IBA 12/2019 - 08/2014
3	Biomarkers (Surrogate Marker)IBA 01/2024 - 08/2019
3	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2017
2	HM781-36BIBA 03/2020 - 10/2019
2	NucleotidesIBA 01/2020 - 10/2019
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 10/2017
1	olaparibIBA 01/2024
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2021
1	(2,4- dihydroxy- 5- isopropylphenyl)- (5- (4- methylpiperazin- 1- ylmethyl)- 1,3- dihydroisoindol- 2- yl)methanoneIBA 11/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020
1	Anaplastic Lymphoma KinaseIBA 01/2018
1	NivolumabIBA 01/2018
1	AntigensIBA 11/2017
1	CarbohydratesIBA 11/2017
1	RNA (Ribonucleic Acid)IBA 09/2015
1	Proteins (Proteins, Gene)FDA Link 12/2014
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 08/2014
1	Indicators and Reagents (Reagents)IBA 03/2012

Therapy/Procedure

12	Therapeutics 01/2024 - 04/2016
4	Precision Medicine 01/2020 - 08/2014
1	Immunotherapy 12/2019
1	Molecular Targeted Therapy 11/2018
1	Prostatectomy (Retropubic Prostatectomy) 03/2011